Click for best price
Prostate Cancer Vaccines Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Vaccines. This report contains market size and forecasts of Prostate Cancer Vaccines in global, including the following market information:
Global Prostate Cancer Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Prostate Cancer Vaccines Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Prostate Cancer Vaccines companies in 2022 (%)
The global Prostate Cancer Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Vaccines include Dendreon Corporation, Bavarian Nordic, Advantagene, OncBioMune Pharmaceuticals, Advaxis immunotherapies, SOTIO, Cleveland BioLabs Inc., Curevac AG and Mediolanum Farmaceutici, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Vaccines Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Prostate Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
Tablet
Injection
Global Prostate Cancer Vaccines Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Prostate Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Prostate Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Prostate Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prostate Cancer Vaccines revenues share in global market, 2022 (%)
Key companies Prostate Cancer Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prostate Cancer Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dendreon Corporation
Bavarian Nordic
Advantagene
OncBioMune Pharmaceuticals
Advaxis immunotherapies
SOTIO
Cleveland BioLabs Inc.
Curevac AG
Mediolanum Farmaceutici
Pfizer Inc.
Vaccitech
Sensei Biotherapeutics
Medigene AG
Ultimovacs
Oncovir Inc.
UbiVac
Momotaro-Gene Inc.
Vaccibody AS
AlphaVax Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Vaccines, market overview.
Chapter 2: Global Prostate Cancer Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Prostate Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prostate Cancer Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Vaccines Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Vaccines Overall Market Size
2.1 Global Prostate Cancer Vaccines Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Vaccines Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Prostate Cancer Vaccines Sales: 2018-2030
3 Company Landscape
3.1 Top Prostate Cancer Vaccines Players in Global Market
3.2 Top Global Prostate Cancer Vaccines Companies Ranked by Revenue
3.3 Global Prostate Cancer Vaccines Revenue by Companies
3.4 Global Prostate Cancer Vaccines Sales by Companies
3.5 Global Prostate Cancer Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prostate Cancer Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prostate Cancer Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Prostate Cancer Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostate Cancer Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Vaccines Market Size Markets, 2022 & 2030
4.1.2 Tablet
4.1.3 Injection
4.2 By Type - Global Prostate Cancer Vaccines Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Prostate Cancer Vaccines Revenue Market Share, 2018-2030
4.3 By Type - Global Prostate Cancer Vaccines Sales & Forecasts
4.3.1 By Type - Global Prostate Cancer Vaccines Sales, 2018-2023
4.3.2 By Type - Global Prostate Cancer Vaccines Sales, 2024-2030
4.3.3 By Type - Global Prostate Cancer Vaccines Sales Market Share, 2018-2030
4.4 By Type - Global Prostate Cancer Vaccines Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Vaccines Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Prostate Cancer Vaccines Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Prostate Cancer Vaccines Revenue Market Share, 2018-2030
5.3 By Application - Global Prostate Cancer Vaccines Sales & Forecasts
5.3.1 By Application - Global Prostate Cancer Vaccines Sales, 2018-2023
5.3.2 By Application - Global Prostate Cancer Vaccines Sales, 2024-2030
5.3.3 By Application - Global Prostate Cancer Vaccines Sales Market Share, 2018-2030
5.4 By Application - Global Prostate Cancer Vaccines Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Vaccines Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Prostate Cancer Vaccines Revenue Market Share, 2018-2030
6.3 By Region - Global Prostate Cancer Vaccines Sales & Forecasts
6.3.1 By Region - Global Prostate Cancer Vaccines Sales, 2018-2023
6.3.2 By Region - Global Prostate Cancer Vaccines Sales, 2024-2030
6.3.3 By Region - Global Prostate Cancer Vaccines Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Prostate Cancer Vaccines Revenue, 2018-2030
6.4.2 By Country - North America Prostate Cancer Vaccines Sales, 2018-2030
6.4.3 US Prostate Cancer Vaccines Market Size, 2018-2030
6.4.4 Canada Prostate Cancer Vaccines Market Size, 2018-2030
6.4.5 Mexico Prostate Cancer Vaccines Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Prostate Cancer Vaccines Revenue, 2018-2030
6.5.2 By Country - Europe Prostate Cancer Vaccines Sales, 2018-2030
6.5.3 Germany Prostate Cancer Vaccines Market Size, 2018-2030
6.5.4 France Prostate Cancer Vaccines Market Size, 2018-2030
6.5.5 U.K. Prostate Cancer Vaccines Market Size, 2018-2030
6.5.6 Italy Prostate Cancer Vaccines Market Size, 2018-2030
6.5.7 Russia Prostate Cancer Vaccines Market Size, 2018-2030
6.5.8 Nordic Countries Prostate Cancer Vaccines Market Size, 2018-2030
6.5.9 Benelux Prostate Cancer Vaccines Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Prostate Cancer Vaccines Revenue, 2018-2030
6.6.2 By Region - Asia Prostate Cancer Vaccines Sales, 2018-2030
6.6.3 China Prostate Cancer Vaccines Market Size, 2018-2030
6.6.4 Japan Prostate Cancer Vaccines Market Size, 2018-2030
6.6.5 South Korea Prostate Cancer Vaccines Market Size, 2018-2030
6.6.6 Southeast Asia Prostate Cancer Vaccines Market Size, 2018-2030
6.6.7 India Prostate Cancer Vaccines Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Prostate Cancer Vaccines Revenue, 2018-2030
6.7.2 By Country - South America Prostate Cancer Vaccines Sales, 2018-2030
6.7.3 Brazil Prostate Cancer Vaccines Market Size, 2018-2030
6.7.4 Argentina Prostate Cancer Vaccines Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostate Cancer Vaccines Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Prostate Cancer Vaccines Sales, 2018-2030
6.8.3 Turkey Prostate Cancer Vaccines Market Size, 2018-2030
6.8.4 Israel Prostate Cancer Vaccines Market Size, 2018-2030
6.8.5 Saudi Arabia Prostate Cancer Vaccines Market Size, 2018-2030
6.8.6 UAE Prostate Cancer Vaccines Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Dendreon Corporation
7.1.1 Dendreon Corporation Company Summary
7.1.2 Dendreon Corporation Business Overview
7.1.3 Dendreon Corporation Prostate Cancer Vaccines Major Product Offerings
7.1.4 Dendreon Corporation Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Dendreon Corporation Key News & Latest Developments
7.2 Bavarian Nordic
7.2.1 Bavarian Nordic Company Summary
7.2.2 Bavarian Nordic Business Overview
7.2.3 Bavarian Nordic Prostate Cancer Vaccines Major Product Offerings
7.2.4 Bavarian Nordic Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Bavarian Nordic Key News & Latest Developments
7.3 Advantagene
7.3.1 Advantagene Company Summary
7.3.2 Advantagene Business Overview
7.3.3 Advantagene Prostate Cancer Vaccines Major Product Offerings
7.3.4 Advantagene Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Advantagene Key News & Latest Developments
7.4 OncBioMune Pharmaceuticals
7.4.1 OncBioMune Pharmaceuticals Company Summary
7.4.2 OncBioMune Pharmaceuticals Business Overview
7.4.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Major Product Offerings
7.4.4 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 OncBioMune Pharmaceuticals Key News & Latest Developments
7.5 Advaxis immunotherapies
7.5.1 Advaxis immunotherapies Company Summary
7.5.2 Advaxis immunotherapies Business Overview
7.5.3 Advaxis immunotherapies Prostate Cancer Vaccines Major Product Offerings
7.5.4 Advaxis immunotherapies Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Advaxis immunotherapies Key News & Latest Developments
7.6 SOTIO
7.6.1 SOTIO Company Summary
7.6.2 SOTIO Business Overview
7.6.3 SOTIO Prostate Cancer Vaccines Major Product Offerings
7.6.4 SOTIO Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 SOTIO Key News & Latest Developments
7.7 Cleveland BioLabs Inc.
7.7.1 Cleveland BioLabs Inc. Company Summary
7.7.2 Cleveland BioLabs Inc. Business Overview
7.7.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Major Product Offerings
7.7.4 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Cleveland BioLabs Inc. Key News & Latest Developments
7.8 Curevac AG
7.8.1 Curevac AG Company Summary
7.8.2 Curevac AG Business Overview
7.8.3 Curevac AG Prostate Cancer Vaccines Major Product Offerings
7.8.4 Curevac AG Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Curevac AG Key News & Latest Developments
7.9 Mediolanum Farmaceutici
7.9.1 Mediolanum Farmaceutici Company Summary
7.9.2 Mediolanum Farmaceutici Business Overview
7.9.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Major Product Offerings
7.9.4 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Mediolanum Farmaceutici Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Prostate Cancer Vaccines Major Product Offerings
7.10.4 Pfizer Inc. Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Inc. Key News & Latest Developments
7.11 Vaccitech
7.11.1 Vaccitech Company Summary
7.11.2 Vaccitech Prostate Cancer Vaccines Business Overview
7.11.3 Vaccitech Prostate Cancer Vaccines Major Product Offerings
7.11.4 Vaccitech Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Vaccitech Key News & Latest Developments
7.12 Sensei Biotherapeutics
7.12.1 Sensei Biotherapeutics Company Summary
7.12.2 Sensei Biotherapeutics Prostate Cancer Vaccines Business Overview
7.12.3 Sensei Biotherapeutics Prostate Cancer Vaccines Major Product Offerings
7.12.4 Sensei Biotherapeutics Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Sensei Biotherapeutics Key News & Latest Developments
7.13 Medigene AG
7.13.1 Medigene AG Company Summary
7.13.2 Medigene AG Prostate Cancer Vaccines Business Overview
7.13.3 Medigene AG Prostate Cancer Vaccines Major Product Offerings
7.13.4 Medigene AG Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Medigene AG Key News & Latest Developments
7.14 Ultimovacs
7.14.1 Ultimovacs Company Summary
7.14.2 Ultimovacs Business Overview
7.14.3 Ultimovacs Prostate Cancer Vaccines Major Product Offerings
7.14.4 Ultimovacs Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Ultimovacs Key News & Latest Developments
7.15 Oncovir Inc.
7.15.1 Oncovir Inc. Company Summary
7.15.2 Oncovir Inc. Business Overview
7.15.3 Oncovir Inc. Prostate Cancer Vaccines Major Product Offerings
7.15.4 Oncovir Inc. Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 Oncovir Inc. Key News & Latest Developments
7.16 UbiVac
7.16.1 UbiVac Company Summary
7.16.2 UbiVac Business Overview
7.16.3 UbiVac Prostate Cancer Vaccines Major Product Offerings
7.16.4 UbiVac Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 UbiVac Key News & Latest Developments
7.17 Momotaro-Gene Inc.
7.17.1 Momotaro-Gene Inc. Company Summary
7.17.2 Momotaro-Gene Inc. Business Overview
7.17.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Major Product Offerings
7.17.4 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 Momotaro-Gene Inc. Key News & Latest Developments
7.18 Vaccibody AS
7.18.1 Vaccibody AS Company Summary
7.18.2 Vaccibody AS Business Overview
7.18.3 Vaccibody AS Prostate Cancer Vaccines Major Product Offerings
7.18.4 Vaccibody AS Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.18.5 Vaccibody AS Key News & Latest Developments
7.19 AlphaVax Inc.
7.19.1 AlphaVax Inc. Company Summary
7.19.2 AlphaVax Inc. Business Overview
7.19.3 AlphaVax Inc. Prostate Cancer Vaccines Major Product Offerings
7.19.4 AlphaVax Inc. Prostate Cancer Vaccines Sales and Revenue in Global (2018-2023)
7.19.5 AlphaVax Inc. Key News & Latest Developments
8 Global Prostate Cancer Vaccines Production Capacity, Analysis
8.1 Global Prostate Cancer Vaccines Production Capacity, 2018-2030
8.2 Prostate Cancer Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostate Cancer Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prostate Cancer Vaccines Supply Chain Analysis
10.1 Prostate Cancer Vaccines Industry Value Chain
10.2 Prostate Cancer Vaccines Upstream Market
10.3 Prostate Cancer Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostate Cancer Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Prostate Cancer Vaccines in Global Market
Table 2. Top Prostate Cancer Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prostate Cancer Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prostate Cancer Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Prostate Cancer Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Prostate Cancer Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prostate Cancer Vaccines Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Prostate Cancer Vaccines Product Type
Table 9. List of Global Tier 1 Prostate Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Prostate Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prostate Cancer Vaccines Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Prostate Cancer Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Prostate Cancer Vaccines Sales (K Units), 2024-2030
Table 16. By Application ? Global Prostate Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Prostate Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prostate Cancer Vaccines Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Prostate Cancer Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Prostate Cancer Vaccines Sales (K Units), 2024-2030
Table 21. By Region ? Global Prostate Cancer Vaccines Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Prostate Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prostate Cancer Vaccines Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Prostate Cancer Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Prostate Cancer Vaccines Sales (K Units), 2024-2030
Table 26. By Country - North America Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prostate Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Prostate Cancer Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Prostate Cancer Vaccines Sales, (K Units), 2024-2030
Table 30. By Country - Europe Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prostate Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Prostate Cancer Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prostate Cancer Vaccines Sales, (K Units), 2024-2030
Table 34. By Region - Asia Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prostate Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Prostate Cancer Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prostate Cancer Vaccines Sales, (K Units), 2024-2030
Table 38. By Country - South America Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prostate Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Prostate Cancer Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Prostate Cancer Vaccines Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prostate Cancer Vaccines Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Prostate Cancer Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prostate Cancer Vaccines Sales, (K Units), 2024-2030
Table 46. Dendreon Corporation Company Summary
Table 47. Dendreon Corporation Prostate Cancer Vaccines Product Offerings
Table 48. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Dendreon Corporation Key News & Latest Developments
Table 50. Bavarian Nordic Company Summary
Table 51. Bavarian Nordic Prostate Cancer Vaccines Product Offerings
Table 52. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bavarian Nordic Key News & Latest Developments
Table 54. Advantagene Company Summary
Table 55. Advantagene Prostate Cancer Vaccines Product Offerings
Table 56. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Advantagene Key News & Latest Developments
Table 58. OncBioMune Pharmaceuticals Company Summary
Table 59. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Offerings
Table 60. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. OncBioMune Pharmaceuticals Key News & Latest Developments
Table 62. Advaxis immunotherapies Company Summary
Table 63. Advaxis immunotherapies Prostate Cancer Vaccines Product Offerings
Table 64. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Advaxis immunotherapies Key News & Latest Developments
Table 66. SOTIO Company Summary
Table 67. SOTIO Prostate Cancer Vaccines Product Offerings
Table 68. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. SOTIO Key News & Latest Developments
Table 70. Cleveland BioLabs Inc. Company Summary
Table 71. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Offerings
Table 72. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Cleveland BioLabs Inc. Key News & Latest Developments
Table 74. Curevac AG Company Summary
Table 75. Curevac AG Prostate Cancer Vaccines Product Offerings
Table 76. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Curevac AG Key News & Latest Developments
Table 78. Mediolanum Farmaceutici Company Summary
Table 79. Mediolanum Farmaceutici Prostate Cancer Vaccines Product Offerings
Table 80. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Mediolanum Farmaceutici Key News & Latest Developments
Table 82. Pfizer Inc. Company Summary
Table 83. Pfizer Inc. Prostate Cancer Vaccines Product Offerings
Table 84. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Pfizer Inc. Key News & Latest Developments
Table 86. Vaccitech Company Summary
Table 87. Vaccitech Prostate Cancer Vaccines Product Offerings
Table 88. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Vaccitech Key News & Latest Developments
Table 90. Sensei Biotherapeutics Company Summary
Table 91. Sensei Biotherapeutics Prostate Cancer Vaccines Product Offerings
Table 92. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Sensei Biotherapeutics Key News & Latest Developments
Table 94. Medigene AG Company Summary
Table 95. Medigene AG Prostate Cancer Vaccines Product Offerings
Table 96. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Medigene AG Key News & Latest Developments
Table 98. Ultimovacs Company Summary
Table 99. Ultimovacs Prostate Cancer Vaccines Product Offerings
Table 100. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Ultimovacs Key News & Latest Developments
Table 102. Oncovir Inc. Company Summary
Table 103. Oncovir Inc. Prostate Cancer Vaccines Product Offerings
Table 104. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Oncovir Inc. Key News & Latest Developments
Table 106. UbiVac Company Summary
Table 107. UbiVac Prostate Cancer Vaccines Product Offerings
Table 108. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. UbiVac Key News & Latest Developments
Table 110. Momotaro-Gene Inc. Company Summary
Table 111. Momotaro-Gene Inc. Prostate Cancer Vaccines Product Offerings
Table 112. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Momotaro-Gene Inc. Key News & Latest Developments
Table 114. Vaccibody AS Company Summary
Table 115. Vaccibody AS Prostate Cancer Vaccines Product Offerings
Table 116. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Vaccibody AS Key News & Latest Developments
Table 118. AlphaVax Inc. Company Summary
Table 119. AlphaVax Inc. Prostate Cancer Vaccines Product Offerings
Table 120. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. AlphaVax Inc. Key News & Latest Developments
Table 122. Prostate Cancer Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Prostate Cancer Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Prostate Cancer Vaccines Production by Region, 2018-2023 (K Units)
Table 125. Global Prostate Cancer Vaccines Production by Region, 2024-2030 (K Units)
Table 126. Prostate Cancer Vaccines Market Opportunities & Trends in Global Market
Table 127. Prostate Cancer Vaccines Market Drivers in Global Market
Table 128. Prostate Cancer Vaccines Market Restraints in Global Market
Table 129. Prostate Cancer Vaccines Raw Materials
Table 130. Prostate Cancer Vaccines Raw Materials Suppliers in Global Market
Table 131. Typical Prostate Cancer Vaccines Downstream
Table 132. Prostate Cancer Vaccines Downstream Clients in Global Market
Table 133. Prostate Cancer Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prostate Cancer Vaccines Segment by Type in 2022
Figure 2. Prostate Cancer Vaccines Segment by Application in 2022
Figure 3. Global Prostate Cancer Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. Prostate Cancer Vaccines Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Vaccines Revenue in 2022
Figure 9. By Type - Global Prostate Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 11. By Type - Global Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 12. By Type - Global Prostate Cancer Vaccines Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Prostate Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 15. By Application - Global Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 16. By Application - Global Prostate Cancer Vaccines Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Prostate Cancer Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Prostate Cancer Vaccines Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 20. By Region - Global Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 21. By Country - North America Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 22. By Country - North America Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 23. US Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 28. Germany Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. France Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 37. China Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. India Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 43. By Country - South America Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 44. Brazil Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Prostate Cancer Vaccines Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Prostate Cancer Vaccines Sales Market Share, 2018-2030
Figure 48. Turkey Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Prostate Cancer Vaccines Revenue, (US$, Mn), 2018-2030
Figure 52. Global Prostate Cancer Vaccines Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Prostate Cancer Vaccines by Region, 2022 VS 2030
Figure 54. Prostate Cancer Vaccines Industry Value Chain
Figure 55. Marketing Channels
